	Eigenkapital Und Reserven		Datum
Agenus	USD -274.14M	80.46M	2025-09
Amgen	USD 8.66B	961M	2025-12
Anika Therapeutics	USD 146.8M	867K	2025-09
Arrowhead Research	USD 568.42M	102.37M	2025-12
AstraZeneca	USD 48.67B	2.78B	2025-12
BioMarin Pharmaceutical	USD 6.09B	30.29M	2025-12
Bristol-Myers Squibb	USD 18.55B	1.06B	2025-09
Celldex Therapeutics	USD 527.16M	71.2M	2025-12
Daiichi Sankyo	JPY 1.71T	57.86B	2025-12
Eli Lilly	USD 26.54B	2.74B	2025-12
Halozyme Therapeutics	USD 48.81M	455.1M	2025-12
Heron Therapeutics	USD 14.88M	42.14M	2025-09
Intrexon	USD 43.17M	75.33M	2024-06
Ionis Pharmaceuticals	USD 617.97M	13.76M	2025-09
Karyopharm Therapeutics	USD -269.26M	30.33M	2025-09
Ligand Pharmaceuticals	USD 1.02B	67.04M	2025-12
MacroGenics	USD 67M	20.38M	2025-09
Neurocrine Biosciences	USD 3.25B	249.5M	2025-12
Pfizer	USD 92.8B	4.11B	2025-09
Regeneron Pharmaceuticals	USD 31.26B	299.1M	2025-12
Rigel Pharmaceuticals	USD 117.61M	35.67M	2025-09
Sangamo BioSciences	USD 19.6M	14.7M	2025-06
Ultragenyx Pharmaceutical	USD 9.16M	142.13M	2025-09
Veracyte	USD 1.26B	36.61M	2025-09

Rigel Pharmaceuticals Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.